Navigation Links
Regenicin, Inc., RGIN - Update
Date:2/2/2011

LITTLE FALLS, N.J., Feb. 2, 2011 /PRNewswire/ -- Regenicin, Inc.(OTC Bulletin Board: RGIN) a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs announced today that its Chairman and CEO, Randall McCoy is currently working with the board on a new Corporate incentive plan designed to encourage and reward the Company's officers, employees and consultants working with Regenicin.  As a show of his own commitment to the Company's growth and stability, Mr. McCoy has pledged to return 22 million of his own personal shares back into Treasury to support the program -- over 26% of the currently issued and outstanding shares of Regenicin."  

"I really believe in the future success of this Company and want all the people who are making it happen to benefit with me," said Mr. McCoy regarding the new incentive program.  "The best way I know how to do that without diluting the existing shareholders is to contribute my own shares to the program.  While this will reduce my holdings by nearly half, I believe it will enhance the overall value of the company creating a win, win for all the shareholders."

When asked about the recent adverse market activity, Mr. McCoy commented that it seemed particularly odd in view of the fact that the Company had incurred no fundamental change or negative developments. "The company remains on track and committed to its original business plan and creating value for the company and its shareholders."

About Regenicin

Regenicin, Inc. (www.regenicin.com) is a development stage biotechnology company. Regenicin is a publicly traded company, with headquarters in New Jersey. Additional information can be found in the company's filings with the Securities and Exchange Commission located at

SOURCE Regenicin, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioCells, Inc., a Cord Blood America Company, to Begin Storing Dental Pulp Stem Cells in Argentina
2. ISTO Technologies, Inc., Completes Enrollment in Phase I NuQu Clinical Trial
3. Johnson & Johnson Consumer Companies, Inc., Unveils CYTOMIMIC(TM) Technology at 68th Annual Meeting of the American Academy of Dermatology
4. LS9, Inc., U.C Berkeley, and JBEI Make Major Breakthrough in Cellulosic Fuels Production
5. BioSpec Global Solutions Inc., contracts with RMF Design & Manufacturing Inc., for production of the TOGs 3000 and 9000 units for U.S. market
6. Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology
7. ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5
8. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
9. Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
10. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
11. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 Through science fairs, workshops, ... for lab equipment, 25 organizations will continue their work ... optics and photonics in daily life with the aid ... organizations, located in 10 countries, are the first of ... by SPIE, the international society for optics and ...
(Date:5/21/2013)... May 21, 2013 Alpha Source, ... , will be exhibiting for the 13th consecutive ... Medical Instrumentation (AAMI) 2013 Conference and Expo. The ... distribute, and manufacture healthcare technologies. This year’s event ... Beach, California. , The three-day event draws ...
(Date:5/21/2013)... Branchburg, NJ (PRWEB) May 21, 2013 ... enhancement industry, has appointed Dale Braddy to Southeastern USA ... proactively bolster its sales muscle in the Southeast. ... a food ingredient brokerage and supplier to food processors ... past 13 years in the food industry and has ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Smarter Security, ... security solutions, today announced that Genzyme, a Sanofi company ... of Door Detective® CL for a multi-use facility in ... in four other Genzyme buildings, this latest order underscores ... the tailgate detection device improving doorway access ...
Breaking Biology Technology:Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3
... The ALS Therapy Development Institute (ALS TDI) ... Silicon Valley entrepreneur, to its board of directors. ALS ... mission to discover and develop treatments that effectively slow ... (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO ) "My ...
... of splitting layered materials to give atom thin "nanosheets" ... of novel two-dimensional nanomaterials with chemical and electronic properties ... energy storage technologies. The collaborative* international research led ... Nanodevices (CRANN), Trinity College Dublin, Ireland, and the University ...
... Van Beek, president and CEO of Van Beek Natural ... dogs and cats, available exclusively through veterinarians. ... containing both probiotics and prebiotics that work together to ... or cat,s GI tract.  Van Beek Natural Science,s formulations ...
Cached Biology Technology:ALS Therapy Development Institute Appoints Anil Godhwani to Board of Directors 2New nanomaterials unlock new electronic and energy technologies 2Van Beek Natural Science Announces New Synacore Digestive Support Product 2
(Date:5/21/2013)... have found that a class of pharmaceuticals can both ... The drugs, known as "TSPO ligands," are currently used ... the effects of TSPO ligand in young adult mice ... aged mice when pathology was quite severe," said lead ... Gerontology. "TSPO ligand reduced measures of pathology and improved ...
(Date:5/21/2013)... in pharmacies and health stores, phosphatidylserine is a ... soy. Proven to improve cognition and slow memory ... experiencing memory impairment. Now a team headed by ... Tel Aviv University,s Department of Human Molecular ... improves the functioning of genes involved in degenerative ...
(Date:5/21/2013)... decades, scientists have developed many devices that can reopen ... generally effective, each of these treatments has drawbacks, including ... from MIT analyzes the potential usefulness of a new ... drug-releasing stents, but may pose fewer risks. With this ... for only a brief period, during which it releases ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Common food supplement fights degenerative brain disorders 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3
... made significant inroads into uncovering the genetic basis of ... overall obesity and 13 that affect fat distribution. The ... million participants, the largest genetic investigation of human traits ... Investigation of ANthropometric Traits) consortium which consists of ...
... be on the way for millions of people on the ... Scientists have reported a key advance in efforts to develop ... a major nuisance to homeowners and a devastating pest to ... fungus that infects a common weed and found that it ...
... , A drug being developed as a treatment for ovarian ... in some patients in a Phase-II clinical trial, an international ... Dana-Farber Cancer Institute in the USA reported the results of ... poster at the 35th Congress of the European Society for ...
Cached Biology News:Studies provide new insights into the genetics of obesity and fat distribution 2Studies provide new insights into the genetics of obesity and fat distribution 3Progress toward first commercial repellent for East Coast's stinker 2Investigational ovarian cancer drug shows promise against platinum resistant disease 2
... unique quantitative and qualitative capabilities of the ... LC/MS/MS Systems with the new Tempo nano ... a rapid solution for high sensitivity validation ... extensive sample preparation with high instrument selectivity ...
... reliable and compact GC-8A is Shimadzu's basic ... and simple to use, the GC-8A supports ... control, on column injection port(s), and analog ... models are available. The GC-8A is only ...
... Peroxisome Proliferator-Activated Receptor-gamma (PPARGamma) Competitor ... and efficient method for studying ... using fluorescence polarization (FP). The ... domain (PPARGamma-LBD) with an N-terminal ...
... call for critical, but time-consuming optimization ... siRNA transfection protocols resulting in less ... be used to efficiently transfect adherent ... without increased cytotoxicity. From start to ...
Biology Products: